Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815691) titled 'Endocannabinoids in Reward' on Sept. 3.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Basic Science. Masking: Double (Participant, Investigator).

Primary Sponsor: Medical University of South Carolina

Condition: Cannabis Use Disorder

Intervention: Drug: Dronabinol

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: September 15, 2026

Target Sample Size: 78

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07815691

Disclaimer: Curated by HT Syndication....